Artificial intelligence (AI) has soared in recent years and has found applications across industries. It has also made huge strides in medical science, particularly in diagnosis. AI systems can evaluate an enormous amount of medical data and images in a short time and can help doctors identify symptoms that may be early signs of disease. In eye care, such technologies have opened the door for diagnosis to be completed in a very short time (and hence for vision loss) in a lot of cases.
But how far has the technology advanced, and can AI be trusted to diagnose eye diseases without human intervention?
How AI is transforming eye care?
Artificial intelligence has been a revolution in ophthalmology and has greatly improved screening, diagnosis and clinical practice. Using computer systems to spot patterns in images and other medical data, AI can perform diagnostic tasks with little human intervention.
Eye care is particularly suited for AI-assisted diagnosis because many eye diseases cause measurable changes in the retina, optic nerve and other structures that can be captured through medical imaging. Technologies such as optical coherence tomography (OCT) and retinal photography allow AI-based algorithms to examine these structures and flag abnormalities that may require further investigation.
AI’s ability to recognize a potential problem, however, does not mean it can independently confirm a diagnosis or decide which treatment a patient needs.
Applications in Major Eye Diseases.
1. Age-related AMD.
Health care professionals say age-related macular degeneration affects the macula, which is the part of the retina responsible for central vision. It makes things like reading and recognising faces more difficult.
AI systems can analyze optical coherence tomography (OCT) images to identify signs of AMD like drusen and intraretinal fluid. These findings can help doctors to see how severe the disease is, how changes occur with time and support decisions about treatment.
In some cases, AI-assisted analysis can also help clinicians assess whether patients might need anti-VEGF injections, which are also used in certain kinds of disease to treat specific types of the disease. The final treatment decision, however, is based on clinical findings and the patient’s clinical state.
2. Glaucoma
Glaucoma is a group of eye diseases that can damage the optic nerve and cause irreversible vision loss. Early stages of the disease may not show any physical symptoms.
AI algorithms can use retinal images and OCT scans to assess changes in the retinal nerve fibre layer (RNFL), ganglion cell layer (GCL) and optic nerve head. These structural changes can help doctors identify people who may have glaucoma or require additional testing.
AI can thus support earlier detection and risk assessment, but it does not eliminate the need for comprehensive eye examinations, visual field testing and clinical evaluation.
3. Diabetic Retinopathy.
Diabetic retinopathy is a complication of diabetes which damages the blood vessels in the retina. If not detected and managed properly, it can lead to severe vision impairment or blindness.
AI-based systems can analyse retinal photographs, such as images captured without dilating the pupils, to identify signs of diabetic retinopathy. These may include microaneurysms, retinal haemorrhages, and other abnormalities.
In areas that have limited access to ophthalmologists, automated screening can help identify patients who require further examination. However, the quality of the images, the severity of the disease and the performance of the specific screening system can affect the outcome. Those with concerning findings may still need a specialist assessment.
4. Retinopathy of Prematurity (ROP).
Retinopathy of prematurity is an eye condition that affects premature infants and can cause childhood blindness if severe disease is not identified and treated in time.
AI studies have shown the capacity to analyse retinal images and assign quantitative severity scores to track the progression of ROP. Systems such as the i-ROP deep-learning framework have been studied to identify abnormal retinal blood vessel patterns and monitor changes in disease severity.
Such tools could also support doctors who deal with premature babies in an environment where specialist resources are limited. However, AI does not substitute for screening, specialist assessment and timely treatment.
5. Macular holes and surgical planning.
AI is also being investigated for applications involving macular holes and other retinal conditions that may require surgery.
OCT imaging provides detailed views of retinal structures, helping doctors assess the size and characteristics of a macular hole. AI-powered image analysis may help to quantify these features and support surgical planning or research into predicting visual recovery.
Other advanced imaging techniques, like OCT angiography, can provide information about retinal blood vessel networks. AI might help analyse these images, but the level to which such methods improve routine clinical outcomes varies by application.
The Challenges: AI Can’t Do Everything on Its Own.
While AI has potential to improve diagnostic accuracy and screening efficiency, doctors will still have to cross-check its findings, determine whether a diagnosis is correct and determine which procedures, if any, need to be done.
AI systems can make mistakes. They may miss abnormalities, flag healthy eyes as potentially diseased or perform differently when presented with images from populations or equipment that were not adequately represented in their training data.
Thus doctors will need to develop and implement appropriate methods for evaluating AI-assisted diagnoses, comparing their findings with common clinical tests, and discussing the findings with the patient. Validation procedures, professional training and guidelines will be key when these systems are increasingly used.
Patients may also question a diagnosis made by a machine. Doctors will need to explain how the technology works, what its findings mean and why further tests or treatment may be recommended in many cases.
AI should support clinical judgment rather than replace the doctor-patient relationship.
Will patients trust AI?
AI has many challenges, including the high implementation costs, equipment and trained personnel shortages in rural areas, and the need for large, reliable training datasets.
But one of the biggest problems could be trust.
Patients often come to doctors when they are worried about their health, their vision and their independence. How will they be able to trust a system that could be alien to them and is developed by commercial organisations?
Healthcare cost concerns can make this more complicated. Hospital consultants already have patients worrying that doctors will recommend unnecessary tests or treatments or even keep them in treatment for longer than they need and increase their bills. These are not evidence that hospitals are doing wrong, but rather why transparency and communication are so important.
Doctors may be caught in the middle. They have to explain the advantages and disadvantages of AI while reassuring patients that a recommendation is based on their medical needs, not on a result or a profit motive.
If patients can’t understand what the technology is and trust it, even a potentially useful diagnostic tool will not be able to deliver what it is supposed to. The World Health Organization has long stressed transparency, accountability, patient autonomy and equitable access in the development and use of AI in healthcare. Such principles are especially important for medical decisions in terms of eyesight and quality of life.
Will AI Help Eye Care be Accessible?
The potential of AI is not limited to advanced hospitals or expensive medical facilities. If implemented well, AI-assisted screening could be a solution to eye care in underprivileged communities.
For instance, retinal images captured at primary healthcare centres could be analysed by validated AI systems to find the patients who need to go to an eye specialist. It could be especially useful for screening diseases like diabetic retinopathy (which can be detected early and treated efficiently).
But this potential is contingent on the availability of suitable cameras, reliable internet or computing infrastructure, trained staff, referral pathways and affordable follow-up care.
If the technology is present only in very expensive hospitals, benefits will be concentrated with patients who can already afford specialist services. AI needs to be backed by public healthcare and rural infrastructure as well as affordable diagnostic services if it is to make a real difference.
What is the future of AI in the field of Ophthalmology?
As a result, we can expect AI to play an increasingly important role in ophthalmic diagnosis, screening and monitoring over the next few years.
It might help doctors to process medical images more efficiently, spot patients who need urgent care and track disease progression. But technological progress in itself can’t ensure better outcomes.
The success of AI in eye care will depend on whether the data it produces is credible, if doctors are able to confirm and explain it, if patients trust the process and whether it benefits people across different income groups and locations.
AI may help detect eye diseases before substantial vision is lost, but it cannot guarantee that every case will be identified or that blindness can always be prevented.
The goal should not be to replace doctors with machines. Doctors should have better tools, patients get timely care and technology is beneficial to as many people as possible.
Comments
Leave a Comment